ICP-490

N/A

Report date: 2024/11/06 14:35:06
NME

Base Information

Drug NameICP-490
Drug Alias NameICP-490
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionZinc finger protein Aiolos degradersDNA-binding protein Ikaros degraders
TargetsDNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsAutoimmune DiseasesMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInnoCare Pharma Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInnoCare Pharma LtdBeijing Innocare Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesMultiple MyelomaLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A